To assess the relationship between the expression levels of immunoproteasome subunits PSMB8 and PSMB9 and melanoma patient survival, we analyzed data from TCGA of 472 melanoma patients for whom RNA-seq data and patient outcome were available (Supplementary Table 1). The gene discussed is PSMB9; the disease is melanoma.